Markets
markets
Luke Kawa

AMD soars again after getting more than 20 price target hikes across Wall Street following its deal with OpenAI

Over the past 24 hours, Wall Street has been scrambling to revise its view on how high shares of Advanced Micro Devices can climb in the wake of its recently announced megadeal with OpenAI.

While the terms of the arrangement may raise some eyebrows, Wall Street is expecting that OpenAI’s big foray into AMD’s AI chips will serve as a validation point and magnet for other potential buyers.

“OpenAI is arguably the most disruptive of GenAI cloud computing customers, and its success is likely to act as a force multiplier for other cloud vendors and LLM providers to accelerate their capex, positive for multiple chip, memory, optical, networking, and foundry suppliers,” wrote Bank of America analyst Vivek Arya, who estimates the agreement could be worth over $100 billion over the next four to six years.

As of publishing, we’ve tallied up 22 cases where the sell side has hiked its price target on the chip designer since news of the deal broke:

  • Jefferies, to $300 from $170 (also upgraded the stock to “buy” and had raised its price target just last week!)

  • Melius, to $300 from $200

  • Barclays, to $300 from $200

  • Wells Fargo, to $275 from $185

  • Argus Research, to $275 from $200

  • Cantor Fitzgerald, to $275 from $200

  • Truist, to $273 from $213

  • Benchmark, to $270 from $210

  • New Street Research, to $265 from $230

  • Bank of America, to $250 from $200

  • Roth Capital, to $250 from $200

  • Morgan Stanley, to $246 from $168

  • Baird, to $240 from $175

  • President Capital Management, to $240 from $186

  • Evercore ISI, to $240 from $188

  • Stifel, to $240 from $190

  • Piper Sandler, to $240 from $190

  • Citi, to $215 from $180

  • Goldman Sachs, to $210 from $150

  • Morningstar, to $210 from $155

  • Bernstein, to $200 from $140

  • Deutsche Bank, to $200 from $150

Bloomberg has average price target data going back to September 2005. Over the past two decades and change, there have been only 12 instances where the two-day average price target rose more than the 16% upward revision since the OpenAI pact was announcement.

  • Jefferies, to $300 from $170 (also upgraded the stock to “buy” and had raised its price target just last week!)

  • Melius, to $300 from $200

  • Barclays, to $300 from $200

  • Wells Fargo, to $275 from $185

  • Argus Research, to $275 from $200

  • Cantor Fitzgerald, to $275 from $200

  • Truist, to $273 from $213

  • Benchmark, to $270 from $210

  • New Street Research, to $265 from $230

  • Bank of America, to $250 from $200

  • Roth Capital, to $250 from $200

  • Morgan Stanley, to $246 from $168

  • Baird, to $240 from $175

  • President Capital Management, to $240 from $186

  • Evercore ISI, to $240 from $188

  • Stifel, to $240 from $190

  • Piper Sandler, to $240 from $190

  • Citi, to $215 from $180

  • Goldman Sachs, to $210 from $150

  • Morningstar, to $210 from $155

  • Bernstein, to $200 from $140

  • Deutsche Bank, to $200 from $150

Bloomberg has average price target data going back to September 2005. Over the past two decades and change, there have been only 12 instances where the two-day average price target rose more than the 16% upward revision since the OpenAI pact was announcement.

More Markets

See all Markets
markets

CoreWeave jumps after expanding its AI compute sales deal with Meta to $21 billion

CoreWeave is popping in premarket trading after announcing it is boosting its deal to offer AI computing capacity to Meta.

The neocloud will now provide approximately $21 billion in AI compute to the social media giant through December 2032.

That increases the size of the agreement by about 50% and the length of the deal by a year when compared to the original pact the two sides inked back in September, which had included an option to expand this commitment — which has seemingly been exercised with today’s announcement.

CoreWeave recently closed a financing deal that management billed as the first of its kind, as it was backed by its chips and Meta’s AI compute purchase. This ability to effectively borrow Meta’s superior creditworthiness helped CoreWeave reduce its cost of debt.

Separately, CoreWeave also announced that it intends to issue $3 billion in senior convertible notes due in 2032 and $1.25 billion in senior notes due in 2031 in separate private offerings.

markets

STAAR Surgical soars after company reported preliminary sales that crushed expecations

STAAR Surgical rose more than 20% in premarket trading after it gave preliminary Q1 sales numbers that crushed Wall Street expectations, which it attributed to booming sales in China and the Americas.

The company, which sells eye implants, said in a press release published Wednesday that it expects to report revenue north of $90 million in the current quarter, compared to the $73 million analysts polled by FactSet are currently penciling in.

The company said sales in China "accounted for the majority of the increase in net sales, along with continued double-digit growth in the Americas." It also noted that sales in the Middle East "were negatively affected by significant geopolitical and macroeconomic challenges, resulting in a decline in sales in parts of those regions."

The stock is up nearly 21% as of 6:25 a.m. ET, having fallen more than 11% from the start of the year to yesterday’s close.

markets

Infleqtion targets revenue growth of 23% in 2026, up from 12% in 2025

Quantum computing firm Infleqtion said it’s aiming to book $40 million in sales this year as it released its 2025 results after the close on Wednesday.

That would be an increase of roughly 23% compared to the $32.5 million in revenues the company generated in 2025, and would mark an acceleration from growth of 12% last year.

The seller of quantum sensors and computers went public via a SPAC in February after carrying a pre-money valuation of $1.8 billion (well below other pure-play peers like Rigetti Computing, IonQ, and D-Wave Quantum).

“We did $29 million in revenue in 2024, and then we announced that we did $50 million of booked and awarded business in 2025. I think that sets a good foundation for significant revenue growth going forward,” CEO Matthew Kinsella told us in February. “I’ve always deeply believed that we need to develop that muscle of commercialization.”

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.